Diseases [C] » Neoplasms [C04] » Neoplasms by Histologic Type » Neoplasms, Connective and Soft Tissue » Neoplasms, Connective Tissue » Neoplasms, Bone Tissue » Osteosarcoma
Diseases [C] » Neoplasms [C04] » Neoplasms by Histologic Type » Neoplasms, Connective and Soft Tissue » Sarcoma » Osteosarcoma
Description
A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed) MeSH
Hierarchy View
Subtype Terms (2)
Sarcoma, Ewing
163 drugs (87 approved, 76 experimental)
Approved Indicated Drugs (3)
Phase 4 Indicated Drugs (4)
Other Experimental Indicated Drugs (2)
Organization Involved with Phase 4 Indications (8)
Organization Involved with Phase 3 Indications (26)
Organization Involved with Phase 2 Indications (85)
Adolescent and Young Adult (AYA) Cancer Program
Autonomous University of Madrid
Case Western Reserve University
FPO Istituto di Ricovero e Cura a Carattere Scientifico
Grupo de Apoio ao Adolescente e a Crianca com Cancer
Grupo Espanol de Investigacion en Sarcomas
Hospital Santa Marcelina, Sao Paulo, Brasil
Icahn School of Medicine at Mount Sinai
National Institute for Health Research, United Kingdom
National Institutes of Health (NIH)
National Pediatric Cancer Foundation
Oregon Health and Science University
People's Liberation Army of China
Sarcoma Alliance for Research through Collaboration
Simcere Pharmaceutical Co., Ltd
Organization Involved with Phase 1 Indications (30)
Evan T.J. Dunbar Neuroblastoma Foundation
Guangdong Xiangxue Precision Medical Technology Co., Ltd
Organization Involved with Other Experimental Indications (4)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.